We are thrilled to see DNlite's predictive technology increasingly adopted by primary care clinics across Taiwan, delivering true precision medicine to patients with diabetes.
Recently, Dr. Hung-Lin Chen, President of the Taiwan Primary Care Diabetes Association, was featured in an exclusive interview with Hello Yishi (a leading health media platform) to discuss the paradigm shift in combating Chronic Kidney Disease (CKD).
In the interview, Dr. Chen highlighted a critical message: "We must transition from passive treatment to proactive prediction." He emphasized how innovative biomarkers like DNlite empower primary care physicians to overcome the diagnostic blind spots of traditional tests, identifying high-risk patients long before irreversible structural damage occurs.
????️ Watch the highlight reel (Mandarin) to see how DNlite is changing the game in primary care:
* Facebook:https://www.facebook.com/share/1C5E1mJbWN/
* Youtube:https://www.youtube.com/watch?v=26xnJFSDXpA
* Eventsite:https://helloyishi-event.com/event.php?id=10
Related News
BPM’s DNlite-IVD103 Secures Regulatory Approval in Singapore
BPM’s DNlite-IVD103 Secures Regulatory Approval in Singapore, Marking Another Major Milestone in the ASEAN Market!
2024/09/26
Press
BPM Sets a New Record: DNlite-IVD103 Secures Dual SFDA Approvals in Saudi Arabia
BPM Sets a New Record: DNlite-IVD103 Secures Dual SFDA Approvals in Saudi Arabia
2023/12/08
Press
BPM Signs Licensing MOU with South Korea’s Boditech Med to Integrate DNlite-IVD103 into POCT Platforms
BPM Signs Licensing MOU with South Korea’s Boditech Med to Integrate DNlite-IVD103 into POCT Platforms
2024/05/09
Press